Skip to main content

Table 3 Proportion of patients achieving remission according to the presence of multimorbidity

From: Impact of multimorbidity on the first ts/bDMARD effectiveness and retention rate after two years of follow-up in patients with rheumatoid arthritis from the BIOBADASER registry

 

Multimorbidity

(CCI score ≥ 3)

N (%)

No multimorbidity

(CCI score < 3)

N (%)

p-value

DAS28 < 2.6 at baseline

7/105 (6.7%)

60/1023 (5.9%)

0.741

DAS28 < 2.6 at 1-year

41/92 (44.6%)

479/949 (50.5%)

0.279

DAS28 < 2.6 at 2-year

23/56 (41.1%)

300/564 (53.2%)

0.083

  1. CCI Charlson Comorbidity Index, DAS28 disease activity score 28